“Knowing which arguments worked or didn’t work with the examiner handling your case; you can draft an office action response to work in your favor.”
Examiner Details
Name
Lien Tran
Art Unit
1793
Group
| Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry | 
Contact Information –
Phone – (571) 272-0903
5 Recent Cases Handled by Lien Tran
| 
                                                                     Case 
                                                                         | 
                                                                
                                                                     Status 
                                                                         | 
                                                                
                                                                     Response Year 
                                                                         | 
                                                                
                                                                     Result & Related Documents 
                                                                         | 
                                                            
|---|---|---|---|
| 
                                                                         151*****
                                                                             
                                                                         | 
                                                                
                                                                     
                                                                                Success: 103, 112 Indefiniteness or Failure to Particularly Point Out and Distinctly Claim 
                                                                         | 
                                                                
                                                                     2021 
                                                                         | 
                                                                
                                                                         Access 
                                                                         | 
                                                            
| 
                                                                         
                                                                                141*****
                                                                             
                                                                         | 
                                                                
                                                                     Success: 103 
                                                                         | 
                                                                
                                                                     2021 
                                                                         | 
                                                                
                                                                         Access 
                                                                         | 
                                                            
| 
                                                                         141*****
                                                                             
                                                                         | 
                                                                
                                                                     Success: 103 
                                                                         | 
                                                                
                                                                     2021 
                                                                         | 
                                                                
                                                                         Access 
                                                                         | 
                                                            
| 
                                                                         162*****
                                                                             
                                                                         | 
                                                                
                                                                     Success: 102 
                                                                        Failure: 103  | 
                                                                
                                                                     2020 
                                                                         | 
                                                                
                                                                         Access 
                                                                         | 
                                                            
| 
                                                                         149*****
                                                                             
                                                                         | 
                                                                
                                                                     Success: 103 
                                                                         | 
                                                                
                                                                     2021 
                                                                         | 
                                                                
                                                                         Access 
                                                                         | 
                                                            

No comment yet, add your voice below!